New Study to Get More Minorities Involved in Genetic Testing
826 articles
A Family Tree Bent but Not Broken by Pancreatic Cancer
When Kay Zedd Kesser looks around her family tree, she sees pancreatic cancer everywhere. But screening saved Kay’s life.
New Immunotherapy Strategy Aimed at High-Risk Population
Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.
At the Table: How to Talk to your Family and Friends about Pancreatic Cancer
David Dessert, Miggie Olsson, and John Moisan share what they learned about how to talk to family and friends about pancreatic cancer.
Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System
A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
New Study Shows Benefit of Chemotherapy after Surgery
Should you have adjuvant chemotherapy–treatment after pancreatic cancer surgery? Dr. Marco Del Chiaro explains that the evidence says “yes.”
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
AACR Special Conference Highlights Advances in Pancreatic Cancer Research
Here are some of the most interesting highlights from the 2024 AACR Special Conference on Pancreatic Cancer Research.
Taking a Systems Biology Approach to Find a New Pancreatic Cancer Target
Dr. Andrea Califano is using systems biology and cell regulators to find new targets in the search for ways to stop pancreatic cancer cells.
Artificial Intelligence and Early Detection of Pancreatic Cancer
How can AI be used in the early detection of pancreatic cancer? Dr. Michael Rosenthal reviews the current state of the field.
Testing Vitamin C as a Cancer Killer
Lewis Cantley’s team is starting clinical trials of vitamin C to gain more information about its role in stopping cancer.
PATHFINDER Blood Test Trial Focused on Early Detection
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.